Alexander Renziehausen
0000-0002-6304-0291
Publication & Citation Trends
Publications
0 total
Inhibition of the angiotensin II type 2 receptor AT2R is a novel therapeutic strategy for glioblastoma OA
Cited by 23
Semantic Scholar
Encapsulation of Small Drugs in a Supramolecule Enhances Solubility, Stability, and Therapeutic Efficacy Against Glioblastoma Multiforme.
Cited by 1
Semantic Scholar
Enhancement of glioblastoma multiforme therapy through a novel Quercetin-Losartan hybrid.
Cited by 21
Semantic Scholar
Encapsulation of Temozolomide in a Calixarene Nanocapsule Improves Its Stability and Enhances Its Therapeutic Efficacy against Glioblastoma OA
Cited by 25
Semantic Scholar
Ablation of reactive astrocytes exacerbates disease pathology in a model of Alzheimer's disease OA
Cited by 64
Semantic Scholar
Development and validation of simple step protein precipitation UHPLC‐MS/MS methods for quantitation of temozolomide in cancer patient plasma samples
Cited by 16
Semantic Scholar
The collagen prolyl hydroxylases are bifunctional growth regulators in melanoma
Cited by 0
Semantic Scholar
Immunotherapy Bridge 2017 and Melanoma Bridge 2017: meeting abstracts OA
Cited by 3
Semantic Scholar
Research Topics
Nanoparticle-Based Drug Delivery
(5)
Renin-Angiotensin System Studies
(5)
Boron Compounds in Chemistry
(5)
Glioma Diagnosis and Treatment
(4)
Supramolecular Chemistry and Complexes
(4)
Affiliations
Hammersmith Hospital
Brain Tumour Research
Genomics England
Imperial College London